Day: December 20, 2022

Reference is made to key information published by Awilco Drilling PLC on 23 November and 16 December 2022. The Sponsored Norwegian Depository Receipts (“SNDRs”) in Awilco Drilling PLC will be traded ex reverse split, new ISIN and new face value as from today 20 December 2022. Name of company: Awilco Drilling PLC Name of issuer of Sponsored Norwegian Depository Receipts (“SNDRs”): Nordic Issuer Services AS Type of corporate action: SNDR reverse split Reverse split ratio: one hundred (100) old SNDRs will give one (1) new SNDRs Ex-date: 20 December 2022 New ISIN: NO0012785098 Following completion of the reverse SNDR split, the new number of shares underlying the SNDRs of Awilco Drilling PLC will be 545.815, each with a par value of GBP 0.65 per share. There will be one SNDR for each underlying share.This information...

Enrollment remains on track to complete in Q1 2023 with results in 1H 2023 Potential to identify advanced adenomas, a type of pre-cancerous polyp often attributed to colorectal cancer (CRC)BERKELEY, Calif. and MAINZ, Germany, Dec. 20, 2022 (GLOBE NEWSWIRE) — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the first patient has been enrolled in eAArly DETECT, Mainz’s U.S. extension of ColoFuture, its European feasibility study evaluating the integration of a portfolio of novel gene expression (mRNA) biomarkers into ColoAlert. Currently, Mainz is commercializing ColoAlert, its highly efficacious, and easy-to-use detection test for colorectal cancer (CRC) across Europe and in select international territories....

Company announcement no. 52 In company announcement no. 9 2022, Spar Nord announced a share buyback programme of up to DKK 225 million. The share buyback was initiated on 15 June 2022. The purpose of the share buyback is to reduce the bank’s share capital by the shares acquired under the programme, and the programme is executed pursuant to Regulation (EU) No 596/2014 of 16 April 2014 (“Market Abuse Regulation”). In week 50, the following transactions were made under the share buyback programme.  Number of shares Average purchase price Transaction value (DKK)Accumulated from last announcement 2,114,500     180,119,57212 December 2022  10,000  99,22  992,20013 December 2022  10,000  99,79  997,90014 December 2022  11,000  100,28  1,103,08015 December 2022  11,000  100,55  1,106,05016 December 2022  12,000  100,29  1,203,480Total...

SAMPO PLC                 STOCK EXCHANGE RELEASE         20/12/2022 at 08:30 am Sampo plc’s share buybacks 19/12/2022 On 19/12/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  14,498 48.59 AQEU  29,761 48.66 CEUX  10,738 48.58 TQEX  55,368 48.62 XHELTOTAL 110,365 48.62  *rounded to two decimals                 On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based...

Due to the Group structure, Verkkokauppa.com reports the parent company separately in accordance with Finnish Accounting Standards (FAS) – The Group is reported in accordance with IFRS Verkkokauppa.com Oyj Stock Exchange Release    20 December 2022 at 8:30am EET Due to the Group structure, Verkkokauppa.com will report the parent company separately, and in accordance with Finnish Accounting Standards (FAS). Verkkokauppa.com has formed a Group since completing an acquisition on 1 April 2022. The change does not affect the Verkkokauppa.com Group’s reporting. The Group reports its year-end financial statements bulletin and financial statements for the financial period ending on 31 December 2022 in accordance with (IFRS), and for the first time, the parent company reports separately in accordance with FAS. Attached to this release are the...

TOKYO and CAMBRIDGE, United Kingdom, Dec. 20, 2022 (GLOBE NEWSWIRE) — Sosei Group Corporation (“the Company”; TSE: 4565) announces its President & CEO Chris Cargill will present at the 41st Annual J.P. Morgan Healthcare Conference. The presentation will take place in-person at the JW Marriott Hotel, San Francisco Union Square, and via webcast at 1:30pm Pacific Standard Time on Wednesday, 11 January 2023. An audio link to the Company’s webcast presentation can be accessed here. Presentation slides will be made available through the investor section of the Company’s Home Page, www.soseiheptares.com. About Sosei HeptaresWe are an international biopharmaceutical group focused on the discovery and early development of new medicines originating from our proprietary GPCR-targeted StaR® technology and structure-based drug design platform...